Centre Hospitalier Jean Rougier

At Centre Hospitalier Jean Rougier, rheumatology research focuses on rheumatoid arthritis, psoriatic arthritis, and osteoporosis. These studies are exploring new ways to improve symptom control, slow disease activity, and protect bone health in people living with chronic musculoskeletal diseases and immune system diseases.

• Testing targeted therapies for moderate to severe rheumatoid arthritis
• Evaluating treatment options for psoriatic arthritis and long-term safety
• Comparing strategies to maintain bone strength in postmenopausal osteoporosis

These trials aim to improve treatment effectiveness and support better long-term outcomes for patients seen at the site.

The site also participates in oncology research across neoplasms and digestive system diseases, including colon carcinoma, anal squamous cell carcinoma, and metastatic oeso-gastric adenocarcinoma. The studies are designed to refine cancer treatment, improve survival, and better match therapy to each patient’s disease profile.

• Assessing new approaches for colorectal cancer and related high-risk disease
• Comparing treatment strategies for locally advanced anal cancer
• Evaluating therapies for metastatic gastroesophageal cancer

Research in this area reflects a strong interest in improving cancer control through more effective and personalized treatment choices.

Another important area includes studies in breast cancer and follicular lymphoma. These trials are examining whether newer treatment combinations can improve disease control for patients with ER+ HER2- breast cancer or newly diagnosed lymphoma, while also supporting longer-term outcomes such as progression-free survival and disease-free survival.

• Comparing treatment approaches for high-risk breast cancer
• Testing combination strategies in previously untreated follicular lymphoma
• Studying ways to extend disease-free survival after standard care

These studies help clarify how emerging therapies may improve care for patients with complex or high-risk cancers.

In the area of bacterial infections and skin and connective tissue diseases, the research includes infections such as catheter-related bloodstream infections and cat scratch disease. The goal is to evaluate more effective infection treatments and improve recovery in patients with difficult-to-manage infectious conditions.

• Assessing treatment options for Staphylococcus aureus bloodstream infections
• Exploring a targeted approach for suppurative cat scratch disease
• Supporting better outcomes in infection-related inflammatory disease

These trials contribute to practical advances in infection care at Centre Hospitalier Jean Rougier and beyond.

Some studies address broader physiological processes, including recovery after acute kidney injury. This research is looking at ways to improve cardiovascular and overall outcomes after hospital discharge, especially for patients who have partially or fully recovered from a serious kidney event.

• Evaluating recovery and follow-up care after acute kidney injury
• Studying strategies to improve cardiovascular outcomes
• Focusing on recovery after critical care treatment

The aim is to better understand post-hospital recovery and support safer long-term care.

The research portfolio also includes studies in less common cancer types and pain conditions, such as neuroendocrine carcinoma, non-small cell lung cancer, and post-surgical neuropathic pain. These trials are testing whether new or adjusted treatment approaches can improve disease control and quality of life.

• Investigating treatment options for rare and advanced cancers
• Comparing approaches for lung cancer care
• Evaluating therapies to reduce post-surgical neuropathic pain

This mix of studies shows a broad clinical research profile with both cancer-focused and symptom-focused investigations.